MLTX · MoonLake Immunotherapeutics · Investor Relations
Market Cap
$1.06B
Shares
85.11M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-09-16 00:00 UTC | 28th Annual Global Investment Conference | Conference |
| 2026-09-24 00:00 UTC | Stifel 2026 Virtual Immunology and Inflammation Forum | Event |
| 2026-10-03 00:00 UTC | EADV Congress 2026 | Event |
| 2026-11-08 00:00 UTC | SHSA 2026 | Event |
| 2026-11-10 00:00 UTC | 8th Annual Wolfe Research Healthcare Conference | Conference |
| 2026-11-11 00:00 UTC | 3rd Annual Guggenheim Healthcare Innovation Conference | Conference |
| 2026-11-11 00:00 UTC | ACR Convergence 2026 | Event |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-11 | Cantor Global Healthcare Conference | Conference |
| 2026-09-10 | Citi's 2026 Biopharma Back to School Conference | Conference |
| 2026-07-29 | BTIG Annual Biotechnology Conference, Virtual | Conference |
| 2026-07-15 | Leerink I&I and Metabolism Therapeutics Forum, Boston, MA | Event |
Source: https://ir.moonlaketx.com/
Key facts
CIK
1821586
CUSIP
61559X104
13F (30d)
115 filings
115 filers
Visit website
Investor relations